Literature DB >> 28432014

TREM2-Ligand Interactions in Health and Disease.

Daniel L Kober1, Tom J Brett2.   

Abstract

The protein n class="Gene">triggering receptor expressed on myeloid cells-2 (n>n class="Gene">TREM2) is an immunomodulatory receptor with a central role in myeloid cell activation and survival. In recent years, the importance of TREM2 has been highlighted by the identification of coding variants that increase risk for Alzheimer's disease and other neurodegenerative diseases. Animal studies have further shown the importance of TREM2 in neurodegenerative and other inflammatory disease models including chronic obstructive pulmonary disease, multiple sclerosis, and stroke. A mechanistic understanding of TREM2 function remains elusive, however, due in part to the absence of conclusive information regarding the identity of endogenous TREM2 ligands. While many TREM2 ligands have been proposed, their physiological role and mechanism of engagement remain to be determined. In this review, we highlight the suggested roles of TREM2 in these diseases and the recent advances in our understanding of TREM2 and discuss putative TREM2-ligand interactions and their potential roles in signaling during health and disease. We develop a model based on the TREM2 structure to explain how different TREM2 ligands might interact with the receptor and how disease risk variants may alter ligand interactions. Finally, we propose future experimental directions to establish the role and importance of these different interactions on TREM2 function.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; immune signaling; inflammation; microglia; neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28432014      PMCID: PMC5485854          DOI: 10.1016/j.jmb.2017.04.004

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  157 in total

Review 1.  LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?

Authors:  Selinda J Orr; Daniel W McVicar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

2.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

3.  The structure of the extracellular domain of triggering receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment.

Authors:  James L Gattis; A Valance Washington; Maia M Chisholm; Laura Quigley; Agnieszka Szyk; Daniel W McVicar; Jacek Lubkowski
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

Review 4.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

5.  ApoE: the role of conserved residues in defining function.

Authors:  Carl Frieden
Journal:  Protein Sci       Date:  2014-12-09       Impact factor: 6.725

6.  Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.

Authors:  Wilbur Song; Basavaraj Hooli; Kristina Mullin; Sheng Chih Jin; Marina Cella; Tyler K Ulland; Yaming Wang; Rudolph E Tanzi; Marco Colonna
Journal:  Alzheimers Dement       Date:  2016-08-09       Impact factor: 21.566

7.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

8.  Initial characterization of TREM-like transcript (TLT)-1: a putative inhibitory receptor within the TREM cluster.

Authors:  A Valance Washington; Laura Quigley; Daniel W McVicar
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

9.  The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Authors:  Christina M Lill; Aina Rengmark; Lasse Pihlstrøm; Isabella Fogh; Aleksey Shatunov; Patrick M Sleiman; Li-San Wang; Tian Liu; Christina F Lassen; Esther Meissner; Panos Alexopoulos; Andrea Calvo; Adriano Chio; Nil Dizdar; Frank Faltraco; Lars Forsgren; Julia Kirchheiner; Alexander Kurz; Jan P Larsen; Maria Liebsch; Jan Linder; Karen E Morrison; Hans Nissbrandt; Markus Otto; Jens Pahnke; Amanda Partch; Gabriella Restagno; Dan Rujescu; Cathrin Schnack; Christopher E Shaw; Pamela J Shaw; Hayrettin Tumani; Ole-Bjørn Tysnes; Otto Valladares; Vincenzo Silani; Leonard H van den Berg; Wouter van Rheenen; Jan H Veldink; Ulman Lindenberger; Elisabeth Steinhagen-Thiessen; Stefan Teipel; Robert Perneczky; Hakon Hakonarson; Harald Hampel; Christine A F von Arnim; Jørgen H Olsen; Vivianna M Van Deerlin; Ammar Al-Chalabi; Mathias Toft; Beate Ritz; Lars Bertram
Journal:  Alzheimers Dement       Date:  2015-04-30       Impact factor: 21.566

10.  Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.

Authors:  Kristi Henjum; Ina S Almdahl; Vibeke Årskog; Lennart Minthon; Oskar Hansson; Tormod Fladby; Lars N G Nilsson
Journal:  Alzheimers Res Ther       Date:  2016-04-27       Impact factor: 6.982

View more
  63 in total

Review 1.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

2.  Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.

Authors:  Wenhui Qu; Ling Li
Journal:  J Neurosci       Date:  2020-11-02       Impact factor: 6.167

Review 3.  Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Wenhui Qu; Ling Li
Journal:  Neurosci Lett       Date:  2019-06-07       Impact factor: 3.046

4.  The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.

Authors:  Yuetiva Deming; Fabia Filipello; Francesca Cignarella; Claudia Cantoni; Simon Hsu; Robert Mikesell; Zeran Li; Jorge L Del-Aguila; Umber Dube; Fabiana Geraldo Farias; Joseph Bradley; John Budde; Laura Ibanez; Maria Victoria Fernandez; Kaj Blennow; Henrik Zetterberg; Amanda Heslegrave; Per M Johansson; Johan Svensson; Bengt Nellgård; Alberto Lleo; Daniel Alcolea; Jordi Clarimon; Lorena Rami; José Luis Molinuevo; Marc Suárez-Calvet; Estrella Morenas-Rodríguez; Gernot Kleinberger; Michael Ewers; Oscar Harari; Christian Haass; Thomas J Brett; Bruno A Benitez; Celeste M Karch; Laura Piccio; Carlos Cruchaga
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

Review 5.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

6.  TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor.

Authors:  Skylar J Ferrara; Priya Chaudhary; Margaret J DeBell; Gail Marracci; Hannah Miller; Evan Calkins; Edvinas Pocius; Brooke A Napier; Ben Emery; Dennis Bourdette; Thomas S Scanlan
Journal:  Cell Chem Biol       Date:  2021-08-09       Impact factor: 8.116

Review 7.  Genetic intolerance analysis as a tool for protein science.

Authors:  Geoffrey C Li; Eliot T C Forster-Benson; Charles R Sanders
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-09-05       Impact factor: 3.747

Review 8.  Immune Signaling in Neurodegeneration.

Authors:  Timothy R Hammond; Samuel E Marsh; Beth Stevens
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

9.  Alzheimer's-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia.

Authors:  Benjamin J Andreone; Laralynne Przybyla; Ceyda Llapashtica; Anil Rana; Sonnet S Davis; Bettina van Lengerich; Karin Lin; Ju Shi; Yuan Mei; Giuseppe Astarita; Gilbert Di Paolo; Thomas Sandmann; Kathryn M Monroe; Joseph W Lewcock
Journal:  Nat Neurosci       Date:  2020-06-08       Impact factor: 24.884

Review 10.  Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.

Authors:  Bhargavi Kulkarni; Dileep Kumar; Natália Cruz-Martins; Satheeshkumar Sellamuthu
Journal:  Mol Neurobiol       Date:  2021-07-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.